(Q44431665)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12767468%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Lactoferrin and lactoferricin inhibit Herpes simplex 1 and 2 infection and exhibit synergy when combined with acyclovir (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12767468%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12767468%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

Håvard Jenssen

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12767468%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Tore Jarl Gutteberg

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12767468%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 May 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12767468%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12767468%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

58

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12767468%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12767468%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

209-215

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12767468%20AND%20SRC:MED&resulttype=core&format=json

Activity of two synthetic amphiphilic peptides and magainin-2 against herpes simplex virus types 1 and 2.

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900214-0

7 January 2021

Lactoferrin and cyclic lactoferricin inhibit the entry of human cytomegalovirus into human fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900214-0

7 January 2021

Lactoferrin and transferrin: functional variations on a common structural framework

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900214-0

7 January 2021

Identification of the bactericidal domain of lactoferrin

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900214-0

7 January 2021

Killing of Candida albicans by lactoferricin B, a potent antimicrobial peptide derived from the N-terminal region of bovine lactoferrin

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900214-0

7 January 2021

Influence of lactoferrin feeding and injection against systemic staphylococcal infections in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900214-0

7 January 2021

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900214-0

7 January 2021

Acyclovir-resistant, pathogenic herpesviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900214-0

7 January 2021

Early fall of circulating iron and rapid rise of lactoferrin in septicemia and endotoxemia: an early defence mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900214-0

7 January 2021

Antiviral effects of plasma and milk proteins: lactoferrin shows potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900214-0

7 January 2021

Inhibition with lactoferrin of in vitro infection with human herpes virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900214-0

7 January 2021

Antibacterial activity in bovine lactoferrin-derived peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900214-0

7 January 2021

Three-dimensional solution structure of lactoferricin B, an antimicrobial peptide derived from bovine lactoferrin

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900214-0

7 January 2021

Characterization of antiviral activity of lactoferrin against hepatitis C virus infection in human cultured cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900214-0

7 January 2021

Synergistic fungistatic effects of lactoferrin in combination with antifungal drugs against clinical Candida isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900214-0

7 January 2021

Direct inactivation of viruses by MCP-1 and MCP-2, natural peptide antibiotics from rabbit leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900214-0

7 January 2021

Lactoferrin inhibits herpes simplex virus type 1 adsorption to Vero cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900214-0

7 January 2021

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900214-0

7 January 2021

Induction of cecropin-like and attacin-like antibacterial but not antiviral activity in Heliothis virescens larvae

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900214-0

7 January 2021

Modulation of natural killer and lymphokine-activated killer cell cytotoxicity by lactoferrin

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900214-0

7 January 2021

Bovine lactoferrin peptidic fragments involved in inhibition of herpes simplex virus type 1 infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900214-0

7 January 2021

A comparative study of the solution structures of tachyplesin I and a novel anti-HIV synthetic peptide, T22 ([Tyr5,12, Lys7]-polyphemusin II), determined by nuclear magnetic resonance

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900214-0

7 January 2021

Potent Antibacterial Peptides Generated by Pepsin Digestion of Bovine Lactoferrin

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900214-0

7 January 2021

Antiviral activities of lactoferrin

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900214-0

7 January 2021

Lactoferrin inhibits HIV-1 replication in vitro and exhibits synergy when combined with zidovudine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900214-0

7 January 2021

Human lactoferrin: a novel therapeutic with broad spectrum potential

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900214-0

7 January 2021

Evaluation of the inactivation of infectious Herpes simplex virus by host-defense peptides.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900214-0

7 January 2021

Bovine lactoferrin and lactoferricin, a peptide derived from bovine lactoferrin, inhibit tumor metastasis in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900214-0

7 January 2021

10.1016/S0166-3542(02)00214-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12767468%20AND%20SRC:MED&resulttype=core&format=json

release_to5rlcicc5a4holpxbpz4z4xwy

4 November 2019

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/to5rlcicc5a4holpxbpz4z4xwy

24 November 2022

mapped directly with Wikidata item

1 reference